|
Market Closed -
Nasdaq
00:00:00 24/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 3.890 USD | -1.27% |
|
+15.77% | -32.58% |
| 10-21 | Unicycive Therapeutics Shares Rise After FDA Accepts Resubmitted NDA | DJ |
| 10-21 | Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission | CI |
Chart calendar Unicycive Therapeutics, Inc.
Upcoming events on Unicycive Therapeutics, Inc.
No events available
Past events on Unicycive Therapeutics, Inc.
| 19/06/2026 | Annual General Meeting | 21:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,68 0,37 83.05% | 0,00 0,00 - | 0,00 0,00 - | 1,37 | 139 | 547 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -20,8 -20,0 -3.7% | -32,1 -30,0 -6.97% | -29,5 -30,9 4.33% | -38,0 | 59,5 | 374 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -30,5 -28,7 -6.32% | -36,7 -22,7 -61.73% | -26,6 -20,7 -28.1% | -33,9 | 69,2 | 471 |
|
Net income Million USD | Released Forecast Spread | -31,4 -29,6 -6.08% | -37,8 -29,9 -26.7% | -26,6 -22,7 -16.87% | -35,4 | 51,5 | 355 |
|
EPS USD | Released Forecast Spread | -12,8 -12,4 -3.5% | -5,60 -5,10 -9.8% | -1,67 -1,59 -5.16% | -1,27 | 1,62 | 8,06 |
| Announcement Date | 28/03/24 | 31/03/25 | 30/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,37 | 15,6 | 26,6 | 34,0 | 70,3 |
|
EBIT Million USD | Released Forecast Spread | -9,26 -7,22 -28.25% | -7,99 -9,22 13.38% | -6,96 -8,88 21.58% | -7,34 -7,13 -2.95% | -7,22 -8,74 17.34% | -8,44 -10,0 15.94% | -10,1 -8,43 -20.32% | -9,12 | -10,2 | 8,28 | 13,6 | 19,0 | 62,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,5 -7,51 -186.71% | 0,57 -7,11 108.02% | -6,45 -8,87 27.35% | -6,01 -7,10 15.31% | -14,7 -9,22 -59.04% | -12,8 -8,08 -58.77% | -1,72 -8,07 78.67% | -10,3 | -8,78 | 9,76 | 14,6 | 18,7 | 62,2 |
|
Net income Million USD | Released Forecast Spread | -22,6 -7,63 -196.29% | -6,21 -7,16 13.16% | -6,45 -8,87 27.35% | -6,01 -7,10 15.31% | -14,7 -8,89 -64.94% | -12,8 -9,63 -33.16% | -1,72 -8,17 78.94% | -10,0 | -9,34 | 9,06 | 12,9 | 16,5 | 59,8 |
|
EPS USD | Released Forecast Spread | -2,60 -0,70 -271.43% | -0,50 -0,62 19.35% | -0,52 -0,70 25.71% | -0,33 -0,53 38.12% | -0,82 -0,49 -67.35% | -0,54 -0,47 -14.29% | -0,06 -0,33 81.74% | -0,35 | -0,32 | 0,09 | 0,28 | 0,39 | 1,15 |
| Announcement Date | 31/03/25 | 14/05/25 | 14/08/25 | 12/11/25 | 30/03/26 | 12/05/26 | 12/08/26 | - | - | - | - | - | - |
| 26/10/2026 |  | Earnings release - Q3 2026 | |
| 26/10/2026 | | Board of Directors Meeting | |
| 26/10/2026 | | Earnings release - Q3 2026 | |
| 26/10/2026 | | Board of Directors Meeting | |
| 26/10/2026 | | Information meeting | 15:00 |
| 26/10/2026 | | Information meeting | 16:00 |
| 27/10/2026 | | Information meeting | 16:30 |
| 27/10/2026 | | Information meeting | 16:00 |
| 27/10/2026 | | Information meeting | 22:00 |
| 27/10/2026 | | Présentation aux Actionnaires / Analystes | 17:00 |
Past sector events for Unicycive Therapeutics, Inc.
| 23/10/2026 | | Information meeting | 16:00 |
| 23/10/2026 | | Extraordinary General Meeting | 10:00 |
| 22/10/2026 | | Earnings release - Q3 2026 | |
| 22/10/2026 | | Earnings presentation | 16:30 |
| 21/10/2026 | | Information meeting | 17:00 |
| 15/10/2026 | | Présentation aux Actionnaires / Analystes | |
| 15/10/2026 | | Sales and Revenue Release - Q3 2026 | |
| 14/10/2026 | | Information meeting | 22:30 |
| 14/10/2026 | | Présentation aux Actionnaires / Analystes | |
| 14/10/2026 | | Information meeting | 00:30 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- UNCY Stock
- Calendar Unicycive Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
